Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study

BACKGROUND: Our retrospective, international study aimed at evaluating the activity and safety of eribulin mesylate (EM) in pretreated metastatic breast cancer (MBC) in a routine clinical setting. METHODS: Patients treated with EM for a locally advanced or MBC between March 2011 and January 2014 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dell’Ova, Mélodie, De Maio, Eléonora, Guiu, Séverine, Roca, Lise, Dalenc, Florence, Durigova, Anna, Pinguet, Frédéric, Bekhtari, Khedidja, Jacot, William, Pouderoux, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599752/
https://www.ncbi.nlm.nih.gov/pubmed/26449988
http://dx.doi.org/10.1186/s12885-015-1673-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599752/
https://www.ncbi.nlm.nih.gov/pubmed/26449988
http://dx.doi.org/10.1186/s12885-015-1673-3

Ejemplares similares